Zivo Bioscience, Inc.
ZIVO· OTC
Filed Nov 21, 2011 · 10-Q · 52 days after period end · 0001078782-11-003377
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Revenue | $35.65K | $19.29K |
| Net Income | -$542.35K | -$589.08K |
| EPS Diluted | -$0.01 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
ended Sep 30, 2011 · filed Nov 21, 2011 · 52 d after period end